CoMotion GLOBAL 2025 Unveils ‘Mayors in Motion’ Initiative: 100+ City Leaders to Accelerate Urban Innovation
6.11.2025 15:00:00 CET | Business Wire | Press Release
CoMotion GLOBAL, the world’s most influential gathering of urban mobility leaders, today announced the launch of Mayors in Motion, a landmark initiative uniting more than 100 global mayors and city leaders to accelerate urban innovation and sustainable development. The program will debut at the upcoming CoMotion GLOBAL conference in Riyadh, December 7–9, underscoring the summit’s growing role as a catalyst for collaboration among the world’s most forward-thinking cities.
Designed to drive progress toward more connected, sustainable, and inclusive cities, Mayors in Motion will serve as a powerful global network for city leaders to exchange insights, coordinate strategies, and champion practical solutions. Through this coalition, participating mayors will collaborate to address critical shared challenges – from decarbonization and digital transformation to equitable access and urban resilience.
The inaugural program features an exceptional lineup of current and former mayors alongside senior government officials from six continents:
- Lord Marvin Rees, Former Mayor of Bristol, England championed urbanization as a means to address global challenges. During his two terms, his administration built more than 14,000 new homes, launched Bristol City Leap – a pioneering £1 billion clean energy investment partnership – and introduced the One City Approach, an award-winning governance model promoting collaborative urban leadership.
- Yvonne Aki-Sawyerr, Mayor of Freetown, Sierra Leone, now in her second term, is adopting a data-driven approach to urban challenges. She is focused on cultivating autonomous, locally designed transportation systems that prioritize affordability and maintenance, while also serving as C40 co-chair.
- Jan Vapaavuori, Former Mayor of Helsinki, Finland brings extensive international experience, having served as Mayor of Helsinki (2017-2021), Vice-President of the European Investment Bank (2015-2017), Finnish Minister of Economic Affairs (2012-2015), Minister of Housing and Urban Planning (2007-2011), Member of the Finnish Parliament (2003-2015), and President of the Finnish Olympic Committee (2020-2024).
- Rohey Malick Lowe, Mayor of Banjul, Gambia, the first female mayor in her city's history, is breaking barriers in local politics and championing initiatives to promote economic growth, community development, and gender equality. She has spearheaded efforts to modernize public infrastructure, creating a cleaner and more sustainable city.
- Dada Morero, Executive Mayor of Johannesburg, South Africa, elected in August 2024, is delivering a transformative agenda for Africa’s most important financial and corporate hub – focused on green energy promotion, urban space transformation, and economic growth. He currently serves as President of the Global Fund for Cities Development (FMDV).
- Mauricio Rodas, Former Mayor of Quito, Ecuador, was the youngest mayor in the capital city's history. During his tenure, he led the construction of Ecuador's first Metro line and implemented numerous initiatives promoting urban sustainability, social equity, and economic development.
- Steve Adler, Former Mayor of Austin, Texas, prioritized tackling Austin's traffic challenges by launching Project Connect, an initiative for a mass public transit system. In September 2016, U.S. Transportation Secretary Anthony Foxx named him a winner of the Mayors' Challenge for Safer People, Safer Streets.
Additional notable speakers include Michael Kpakpo Allotey, Mayor of Accra, Ghana; Chiri Babu Maharjan, Mayor of Lalitpur, Nepal; Berry Vrbanovic, Mayor of Kitchener; and Jaime Pumarejo, Former Mayor of Barranquilla, Colombia; Fatimetou Abdel Malick, Former Mayor of Tevragh Zeina, Mauritania; Dr Hazel Nasiphi Moya, Executive Mayor of City of Tshwane, Pretoria; Diana Caiza, Mayor of Ambato, Ecuador; Joséphine Solange Anaba Mbarga, Mayor of Nkolmetet, Cameroon; Hon. Yvonne Eyidi, Mayor of Nkongsamba, Cameroon; Chaudhry Muhammad Ali Randhawa, Chairman Capital Development Authority & Chief Commissioner of Islamabad; Johra Said Ali, Mayor of Nakuru, Kenya; Emad Al-Azzam, Mayor of Irbid, Jordan; and Manuel de Araújo, Mayor of Quelimane, Mozambique.
Beyond this distinguished lineup of mayors, the summit will convene CEOs, policymakers, investors, academics, entrepreneurs, and innovators to shape urban mobility ecosystems and advance the future of smart cities.
"CoMotion GLOBAL has become the premier platform for the world's most forward-thinking city leaders to come together," says John Rossant, Founder and CEO of CoMotion. "We're honored to welcome such a diverse group of mayors and government officials to Riyadh, one of the world's fastest-rising hubs of innovation. Their leadership and vision are essential as cities everywhere navigate the challenges and opportunities of a rapidly evolving mobility landscape."
Explore the future of mobility and collaboration in Riyadh. To learn more and apply for a complimentary public sector pass, visit: www.comotionglobal.com.
About CoMotion
CoMotion is the world’s leading platform where the most influential leaders, companies, startups, and policymakers meet to shape the future of mobility. With flagship events in Riyadh, Los Angeles, and Miami, CoMotion fosters meaningful dialogue and catalyzes investments that advance sustainable and equitable transportation worldwide.
View source version on businesswire.com: https://www.businesswire.com/news/home/20251106843869/en/
Contacts
Media
Kristin Ford-Glencross
comotion@antennagroup.com
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 202624.10.2026 10:15:00 CEST | Press Release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data from multiple differentiated investigational medicines across its priority solid tumor disease areas at the European Society for Medical Oncology (ESMO) Congress 2026 (October 23–27, Madrid). The presentations span gastrointestinal, lung, and breast cancers, and reflect the growing momentum of BeOne’s solid tumor franchise. Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “At ESMO, we are showing how our strategy of matching the right modality to disease biology is translating into meaningful clinical progress. Our GPC3 x 4-1BB bispecific antibody continues to be well tolerated and demonstrates durable activity with longer follow up in patients with heavily pre-treated hepatocellular carcinoma, while the first clinical data from our brain-penetrant PRMT5 inhibitor and CEA-targeting ADC expand our innovation in non-small cell lung cancer. Alongsi
Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 19:42:00 CEST | Press Release
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Society of Nephrology (ASN) Kidney Week 2026 in Denver, Colorado, and advancement of the povetacicept clinical research program in IgAN. Vertex will also host an investor event during ASN on October 23 at 6:15-7 p.m. MDT (8:15-9 p.m. EDT). Further details are below. Data being presented include a pre-specified Week 36 interim analysis of the ongoing Phase 3 RAINIER trial of povetacicept, an engineered fusion protein and dual inhibitor of the BAFF (B cell activating factor) and APRIL (a proliferation inducing ligand) cytokines, in immunoglobulin A nephropathy (IgAN). RAINIER met its primary endpoint, with povetacicept achieving a 52.0% reduction from baseline in proteinuria at Week 36 and a statistically significant and clinically meaningful 49.8% reduction versus placebo (
Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:19:00 CEST | Press Release
Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com
BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press Release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “Following the U.S. approval in August, these longer-term data provide further evidence supporting TEVIMBRA plus ZIIHERA and chemotherapy as the new standard of care in all first-line HER2-positive advanced gastroesophageal adenocarcinoma patients, regardless of PD-L1 sta
inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 15:00:00 CEST | Press Release
inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a leading Central Asian economy, this gives the companies a clear basis to assess autonomous ride-hailing in practice. The three companies will evaluate the technical, operational, regulatory and
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom